UC Davis-led trial of Zynlonta combination in DLBCL marked suspended as of Nov. 16 update
The phase 2 study testing loncastuximab tesirine and rituximab followed by DA-EPOCH-R in high-risk diffuse large B-cell lymphoma is on hold pending enrollment allocation.
ClinicalTrials.gov